AstraZeneca signs Zurampic licensing deal with Grünenthal

06-06-2016

AstraZeneca signs Zurampic licensing deal with Grünenthal

Artco / Shutterstock.com

Pharmaceutical company AstraZeneca has agreed a licensing deal with German drug maker Grünenthal centring on gout treatment drug Zurampic (lesinurad).


AstraZeneca, Grünenthal, patent, licensing, lesinurad, Zyloprim, Zurampic, Luke Miels, gout,

LSIPR